Background and Purpose: Natriuretic peptides have led the way as a diagnostic and
prognostic tool for the diagnosis and management of heart failure (HF). More recent …

Cardiac arrest effectiveness trials have traditionally reported outcomes that focus on
survival. A lack of consistency in outcome reporting between trials limits the opportunities to …

BACKGROUND: Prospective, single-center trials have shown that the implementation of the
Kidney Disease: Improving Global Outcomes (KDIGO) recommendations in high-risk …

Purpose Care bundles are recommended in patients at high risk for acute kidney injury
(AKI), although they have not been proven to improve outcomes. We sought to establish the …

Heart failure is a global public health problem that affects more than 26 million people
worldwide. The global burden of heart failure is growing and is expected to increase …

Heart failure (HF) is a complex syndrome that affects mortality/morbidity and acts at different
levels in the patient's life, resulting in a drastic impairment in multiple aspects of daily …

The natriuretic peptides are important tools to establish diagnosis and prognosis in heart
failure (HF). With application of therapies for HF, changes in both B-type natriuretic peptide …

Background Prediction of acute kidney injury (AKI) following cardiac surgery is unreliable
through the use of serum creatinine or urinary output alone. Cell cycle arrest urinary …

Abstract Background: The GUIDE-IT (GUIDing Evidence Based Therapy Using Biomarker
Intensified Treatment in Heart Failure) trial demonstrated that a strategy to “guide” …

Objective This study examines the impact of major depressive disorder (MDD) and its
treatment on quality of life (QOL). Method From the Sequenced Treatment Alternatives to …